These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8524946)

  • 41. Effect of methylguanidine, guanidine and structurally related compounds on constitutive and inducible nitric oxide synthase activity.
    Sorrentino R; Sautebin L; Pinto A
    Life Sci; 1997; 61(13):1283-91. PubMed ID: 9324070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversibility of inhibition of human type II nitric oxide synthase.
    Nicholls DJ; Kirk A; Wallace AV
    Biochem Soc Trans; 1996 Feb; 24(1):20S. PubMed ID: 8674663
    [No Abstract]   [Full Text] [Related]  

  • 43. Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase.
    Hallinan EA; Tsymbalov S; Finnegan PM; Moore WM; Jerome GM; Currie MG; Pitzele BS
    J Med Chem; 1998 Mar; 41(6):775-7. PubMed ID: 9526553
    [No Abstract]   [Full Text] [Related]  

  • 44. NO inhibitors and septic shock.
    Cohen J; Silva A
    Lancet; 1992 Mar; 339(8795):751. PubMed ID: 1347627
    [No Abstract]   [Full Text] [Related]  

  • 45. Selective inducible nitric oxide synthase inhibition in septic shock.
    Beilman GJ
    Crit Care Med; 2001 Nov; 29(11):2230-1. PubMed ID: 11700433
    [No Abstract]   [Full Text] [Related]  

  • 46. Role of nitric oxide in glomerular physiology and pathophysiology.
    Gabbai FB; Garcia GE; Blantz RC; De Nicola L
    Adv Nephrol Necker Hosp; 1995; 24():3-18. PubMed ID: 7572414
    [No Abstract]   [Full Text] [Related]  

  • 47. Reinforcement therapy using nitric oxide synthase inhibitors against endotoxin shock in dogs.
    Suga H; Nakagawa T; Soga Y; Deguchi Y; Suzuki T; Miyoshi N; Imamura Y; Fukuda M
    Surg Today; 2006; 36(9):811-7. PubMed ID: 16937286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of nitric oxide synthesis.
    Lefroy DC; Tousoulis D; Crake T
    Lancet; 1993 Dec; 342(8885):1487-8. PubMed ID: 7902503
    [No Abstract]   [Full Text] [Related]  

  • 49. Vascular biology: relevance of nitric oxide in vascular and nonvascular tissue with normal and decreased renal function.
    Blantz RC
    Blood Purif; 1994; 12(1):30-5. PubMed ID: 7527221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitric oxide: moving towards the clinic.
    Kilbourn RG
    Mol Med Today; 1996 Aug; 2(8):324. PubMed ID: 8796916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overproduction of nitric oxide in cytokine-mediated and septic shock.
    Kilbourn RG; Griffith OW
    J Natl Cancer Inst; 1992 Jun; 84(11):827-31. PubMed ID: 1375655
    [No Abstract]   [Full Text] [Related]  

  • 52. Relaxin inhibits histamine release from mast cells: involvement of nitric oxide production.
    Masini E; Di Bello MG; Bani D; Bigazzi M; Bani Sacchi T; Mannaioni PF
    Inflamm Res; 1995 Apr; 44 Suppl 1():S12-3. PubMed ID: 8520977
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of NO synthesis in septic shock.
    Hotchkiss RS; Karl IE; Parker JL; Adams HR
    Lancet; 1992 Feb; 339(8790):434-5. PubMed ID: 1346700
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibition of nitric oxide synthase during sepsis: revival because of isoform selectivity?
    Stahl W; Matejovic M; Radermacher P
    Shock; 2010 Sep; 34(3):321-2. PubMed ID: 20601934
    [No Abstract]   [Full Text] [Related]  

  • 55. Modulating the L-arginine-nitric oxide pathway in septic shock: choosing the proper point of attack.
    Fink MP
    Crit Care Med; 1999 Sep; 27(9):2019-22. PubMed ID: 10507634
    [No Abstract]   [Full Text] [Related]  

  • 56. Drugs which modulate nitric oxide homeostasis are likely to provide therapeutic benefit in cardiovascular disease.
    Thiemermann C
    Cardiovasc Res; 1993 Dec; 27(12):2104. PubMed ID: 8313413
    [No Abstract]   [Full Text] [Related]  

  • 57. Nitric oxide synthase inhibition in septic shock--a question of the right time, the right drug, and the right model?
    Bone HG
    Crit Care Med; 1998 Dec; 26(12):1945-7. PubMed ID: 9875895
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of NO synthesis in septic shock.
    Geroulanos S; Schilling J; Cakmakci M; Jung HH; Largiader F
    Lancet; 1992 Feb; 339(8790):435. PubMed ID: 1346701
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute purulent sinusitis triggered by topical nasal nitric oxide synthase inhibition.
    Lundberg JO
    Am J Respir Crit Care Med; 2005 Aug; 172(4):512-3. PubMed ID: 16081564
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiovascular derangement in septic shock and nitric oxide.
    Lodato RF
    J Crit Care; 1996 Dec; 11(4):151-4. PubMed ID: 8977990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.